Anbio Biotechnology (NNNN) Cash & Current Investments (2023 - 2025)
Historic Cash & Current Investments for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $13429.0 billion.
- Anbio Biotechnology's Cash & Current Investments changed N/A to $13429.0 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $13429.0 billion, marking a year-over-year change of. This contributed to the annual value of $11.8 million for FY2024, which is 2136.89% up from last year.
- As of Q2 2025, Anbio Biotechnology's Cash & Current Investments stood at $13429.0 billion.
- Anbio Biotechnology's Cash & Current Investments' 5-year high stood at $13429.0 billion during Q2 2025, with a 5-year trough of $9.7 million in Q4 2023.
- In the last 3 years, Anbio Biotechnology's Cash & Current Investments had a median value of $11.8 million in 2024 and averaged $4476.3 billion.
- The largest annual percentage gain for Anbio Biotechnology's Cash & Current Investments in the last 5 years was 2136.89% (2024), contrasted with its biggest fall of 2136.89% (2024).
- Over the past 3 years, Anbio Biotechnology's Cash & Current Investments (Quarter) stood at $9.7 million in 2023, then grew by 21.37% to $11.8 million in 2024, then surged by 114171106.58% to $13429.0 billion in 2025.
- Its Cash & Current Investments stands at $13429.0 billion for Q2 2025, versus $11.8 million for Q4 2024 and $9.7 million for Q4 2023.